Disassembly of Alzheimer's amyloid fibrils by functional upconversion nanoparticles under near-infrared light irradiation

Colloids Surf B Biointerfaces. 2019 Sep 1:181:341-348. doi: 10.1016/j.colsurfb.2019.05.053. Epub 2019 May 24.

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disease characterized by cognitive and memory function impairment. Studies have shown that the overproduction and further misfolding of amyloid polypeptide (Aβ) are the main causes of AD. Therefore, how to reduce Aβ species, especially to disassemble the preformed amyloid aggregates, has become the focus of related research. Photodynamic therapy (PDT) using normal photosensitizers eg. porphyrins, is a traditional way of inhibiting amyloid aggregation or degrading the amyloid aggregates, but UV light irradiation presents a side effect for the damage of normal tissue, which limits its medical application. Upconversion nanoparticles (UCNPs) is a luminous material which can be modified by photodynamic agent to form the complex generating reactive oxygen species (ROS) with noninvasive light irradiation. It presents a good advantage in the disassembly of amyloid aggregates via ROS in noninvasive light irradiation. Herein, we prepared β-NaYF4:Yb/Er@SiO2@RB by combing UCNPs with photosensitizer to disassemble preformed Aβ aggregates under near-infrared light. The results displayed upconversion nanomaterials could degrade Aβ1-42 fibrils effectively by photo-generating ROS, which demonstrated that the functional UCNPs may have potential applications in the treatment of amyloid diseases in future.

Keywords: Amyloid β disassembly; Near infrared light irradiation; Neurodegenerative disease; Surface modification of nanomaterials; Up-conversion nanomaterials.

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism
  • Amyloid / antagonists & inhibitors*
  • Amyloid / chemistry
  • Amyloid / metabolism
  • Humans
  • Infrared Rays*
  • Nanoparticles / chemistry*
  • Particle Size
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology*
  • Protein Aggregates / drug effects
  • Reactive Oxygen Species / metabolism
  • Surface Properties

Substances

  • Amyloid
  • Photosensitizing Agents
  • Protein Aggregates
  • Reactive Oxygen Species